Your browser doesn't support javascript.
loading
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma.
Costa, Luciano J; Chhabra, Saurabh; Medvedova, Eva; Dholaria, Bhagirathbhai R; Schmidt, Timothy M; Godby, Kelly N; Silbermann, Rebecca; Dhakal, Binod; Bal, Susan; Giri, Smith; D'Souza, Anita; Hall, Aric; Hardwick, Pamela; Omel, James; Cornell, Robert F; Hari, Parameswaran; Callander, Natalie S.
Afiliação
  • Costa LJ; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Chhabra S; O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL.
  • Medvedova E; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Dholaria BR; Oregon Health & Science University, Portland, OR.
  • Schmidt TM; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN.
  • Godby KN; University of Wisconsin, Madison, WI.
  • Silbermann R; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Dhakal B; O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL.
  • Bal S; Oregon Health & Science University, Portland, OR.
  • Giri S; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • D'Souza A; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Hall A; O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL.
  • Hardwick P; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Omel J; O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL.
  • Cornell RF; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Hari P; University of Wisconsin, Madison, WI.
  • Callander NS; O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL.
J Clin Oncol ; 40(25): 2901-2912, 2022 09 01.
Article em En | MEDLINE | ID: mdl-34898239
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Albânia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Albânia